Mitotech

Mitotech are developing therapies that are targeting excessive reactive oxygen species, a harmful byproduct of mitochondrial energy production. During the aging process the mitochondria become increasingly inefficient at producing cellular energy and the level of reactive oxygen species they produce increases, these molecules bounce around inside the cell and can damage the mitochondrial DNA if striking it. Damaged mitochondria become dysfunctional and typically produce even more reactive oxygen species and are thought to be one of the reasons we age.